Loading
Latest filing published 11 Oct 2023 for Exelerate Capital Corp. (formerly Exelerate Health Inc.), €436.
Michael Manford Boyd discloses dealings in Exelerate Capital Corp. (formerly Exelerate Health Inc.) to SEDI. The record holds 2 filings, all for trades on 11 October 2023.
No open-market sale appears; the market trades are 2 purchases worth €990. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket.
The record was last updated on 11 October 2023 with an open-market purchase (€436) in Exelerate Capital Corp. (formerly Exelerate Health Inc.). These figures are compiled from regulatory filings published by SEDI. They describe what insiders did and are not a recommendation.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
2 of 2 declarations